Pricing Log in Create free account
Saturday 17 October 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

86.06 1.65 −1.88%
Market cap
$33.1B
P/E
33.2×
Fwd P/E
29.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

DexCom, Inc. (DXCM) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, DexCom, Inc. (DXCM) trades at a P/E ratio of 33.2×. Over the past ten years it has ranged from 0.0× (December 2019) to 311× (November 2018); the current reading is higher than 46% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 30.9× (41.65%)
FY2024 52.9× (39.40%)
FY2023 87.3× (33.04%)
FY2022 130× (53.62%)
FY2021 281× 292.28%
FY2020 71.7× (64.30%)
FY2019 201× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 26.0× (0.62%)
Mar 2026 26.2× (15.24%)
Dec 2025 30.9× (15.13%)
Sep 2025 36.4× (39.16%)
42 more quarters

Against its own ten years

Low 0.0× High 311×
Ten-year median 39.8×
Current reading's percentile 9

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 16.0×
BSX Boston Scientific Corporation compare 17.9×
PHG Koninklijke Philips N.V. compare 18.8×
ZBH Zimmer Biomet Holdings, Inc. compare 23.0×
STE STERIS plc compare 27.1×
DXCM DexCom, Inc. 33.2×
SNN Smith & Nephew SNATS, Inc. compare 35.4×
EW Edwards Lifesciences Corporation compare 49.8×
PEN Penumbra, Inc. compare 78.4×
Medical Devices industry median 23.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DXCM